NEW YORK, March 28, 2018 -- Global Sinusitis Treatment Market size is expected to reach USD 50.41 Billion in 2024, at a CAGR of 12.4% from 2018 to 2024. Factors propelling the growth of the market include growing number of chronic sinusitis patients coupled with technological advancements in sinus surgery. Moreover, growing awareness among people regarding its detection and treatment, and investment in research and development activities by major players is further propelling the growth of the global sinusitis treatment market.
The report segments the global sinusitis treatment market by Types (chronic sinusitis, acute sinusitis, sub-acute sinus, and recurrent sinusitis), by Age Group (children, teenagers, and adults), by Types of Treatment (oral decongestants, expectorants, nasal spray, antibiotics, antihistamines, surgery (functional endoscopic sinus surgery (FESS), image guided surgery, caldwell Luc operation) and others) by End-User (hospitals, surgical centers, and pharmacy store) and by Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa). The report studies the global sinusitis treatment market over the forecast period (2018-2024).
Browse full research report with TOC on “Global Sinusitis Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024” at: https://www.energiasmarketresearch.com/global-sinusitis-treatment-market-outlook/
To purchase report: [email protected]
Sinuses are hollow spaces located in the bone around the nose that is connected to the nose through a small narrow channel. Sinusitis refers to infection of sinuses and it generally occurs due to bacteria, viruses or allergy, and in some cases due to autoimmune problems. The infection causes inflammation of the sinus lining resulting in facial pain and blocked or runny nose.
Key Findings from Global Sinusitis Treatment Market
- The global sinusitis treatment market is expected to grow from USD 22.26 billion in 2017 to USD 50.41 billion in 2024, at a CAGR of 12.4% from 2018 to 2024
- On the basis of Types, the chronic sinusitis segment holds the largest share of the global sinusitis treatment market in 2017 due to growing number of chronic sinusitis patients with long-term blockage and inflammation condition
- Based on Age Group, the adults segment holds the major share of the global sinusitis treatment market
- Geographically, North America holds the major share of global sinusitis treatment market in 2017, due to growing incidence of sinusitis coupled with developments in sinus surgery in the region
- Key players in global sinusitis treatment market are Novartis AG., Zydus Cadila, Beximco Pharmaceuticals Ltd, Abbott Laboratories, Reddys Lab, Bristol-Myers Squibb, Bayer AG, Sun Pharmaceutical Industries Ltd., Eli Lilly, and Sanofi, among others
Advancement in Sinusitis Surgery Driving the Global Sinusitis Treatment Market
Sinusitis disease affects millions of people every year and is a major health problem across the globe. Sinusitis is the inflammation of the of the air cavities within the passages of the nose. It is generally caused by infection (bacteria, and viruses), chemical, allergies, and autoimmune problems. The purpose of sinus surgery is to remove the unhealthy sinus tissue and create a better pathway. The technological advancements (surgical laser technologies) in sinus surgery improve the patient’s life and have fewer side-effects. The technology uses a laser to remove the unwanted sinus tissue and provides relief from chronic sinusitis with less bleeding and pain.
Global Sinusitis Treatment Market- Regional Insight
Geographically, the global sinusitis treatment market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa. North America holds the major share of the global sinusitis market due to growing incidence of sinusitis coupled with developments in sinus surgery in the region. Asia-Pacific region is expected to witness fastest growth rate during the forecast period owing to the growing awareness among people regarding the diagnosis and treatment of sinusitis, and increasing number of bacteria and viruses infections in the region.
About Energias Market Research Pvt. Ltd. -
Energias Market Research Pvt. Ltd. publishes high quality reports, in-depth market research studies, to help clients obtain investment level clarity on current business scenario, trends and segmentation for their future developments. We are committed to our client’s needs, by providing high quality custom reports solutions best fit for strategy development and implementation to high return of invest (RoI). We believe that exceptional problems need expertise to solve, and with the help of our industries expertise we are able to offer an in depth understanding of what’s crucial, what’s applicable, and what it takes to ensure accomplishment in any business or venture.
With a wide range of expertise from various industrial sectors and more than 50 industries that includes energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.
Contact:
Alan Andrews
Business Development Manager
Phone: +1-716-239-4915
For any queries email us: [email protected]
To purchase report: [email protected]
Visit: https://www.energiasmarketresearch.com/


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Anta Sports Expands Global Footprint With Strategic Puma Stake
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



